Response to “The WHO classification of haematolymphoid tumours” (Editorial)
暂无分享,去创建一个
E. Campo | A. Zelenetz | J. Winter | E. Jaffe | S. Swerdlow | M. Cazzola | H. Döhner | D. Arber | A. Tefferi | L. Quintanilla‐Martinez | J. Cook | R. Hasserjian | A. Orazi | M. Dreyling | D. Scott | Jane N. Winter
[1] A. Rosenwald,et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms , 2022, Leukemia.
[2] I. Cree. The WHO Classification of Haematolymphoid Tumours , 2022, Leukemia.
[3] Y. Natkunam,et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms , 2022, Leukemia.
[4] Mario Cazzola,et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.
[5] N. Harris,et al. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. , 2008, Blood.
[6] R. Advani,et al. The World Health Organization Classification of Lymphoid Neoplasms , 2013 .